Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy
Thomas C. Thannickal, Joshi John, Ling Shan, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 447
Open Access | Times Cited: 117

Showing 26-50 of 117 citing articles:

Reduction of orexin-expressing neurons and a unique sleep phenotype in the Tg-SwDI mouse model of Alzheimer’s disease
Yan Wu, Narayan R. Bhat, Meng Liu
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Sleep Loss and Substance Use Disorders: An Issue from Adolescents to Adults
Ana Clementina Equihua-Benítez, Rodolfo Espinoza-Abad, Fabio García‐García
Behavioral Sciences (2025) Vol. 15, Iss. 2, pp. 220-220
Open Access
The Involvement of Brain Norepinephrine Nuclei in Eating Disorders
Carla L. Busceti, Gloria Lazzeri, Francesca Biagioni, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106069-106069
Closed Access
Determinants of substance use patterns in patients with narcolepsy type 1: a multi-center comparative cross-sectional study
Laure Peter‐Derex, Emmanuel Fort, Benjamin Putois, et al.
Sleep Medicine (2025) Vol. 129, pp. 148-166
Open Access
The Complexly Parcellated, Yet Quantitatively Reduced, Orexinergic/Hypocretinergic System of Humans
Illke B. Malungo, Ayanda Ngwenya, Mads F. Bertelsen, et al.
The Journal of Comparative Neurology (2025) Vol. 533, Iss. 2
Open Access
Drugs of abuse drive neurotransmitter plasticity that alters behavior: implications for mental health
Marta Pratelli, Nicholas C. Spitzer
Frontiers in Behavioral Neuroscience (2025) Vol. 19
Open Access
Chronic but not acute morphine exposure reversibly impairs spike generation and repetitive firing in a functionally distinct subpopulation of orexin neurons
Emma Berry, Ellen N. Huhulea, Masaru Ishibashi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats
Joaquin E. Douton, Corinne Augusto, Brooke Stoltzfus, et al.
Behavioural Pharmacology (2020) Vol. 32, Iss. 4, pp. 265-277
Open Access | Times Cited: 36
A circuit perspective on narcolepsy
Antoine Adamantidis, Markus H. Schmidt, Matt Carter, et al.
SLEEP (2020) Vol. 43, Iss. 5
Open Access | Times Cited: 33
The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System
Jennifer E. Fragale, Morgan H. James, Jorge A. Avila, et al.
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 117-127
Open Access | Times Cited: 29
Orexin (hypocretin) and addiction
Jacqueline B. Mehr, Michelle M. Bilotti, Morgan H. James
Trends in Neurosciences (2021) Vol. 44, Iss. 11, pp. 852-855
Open Access | Times Cited: 29
The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11
Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior
Jessica M. Illenberger, Francisco J. Flores‐Ramirez, Glenn Pascasio, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 7, pp. 647-660
Closed Access | Times Cited: 4
New directions in modelling dysregulated reward seeking for food and drugs
Robyn M. Brown, Christopher V. Dayas, Morgan H. James, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 1037-1048
Open Access | Times Cited: 23
Physiological Role of Orexin/Hypocretin in the Human Body in Motivated Behavior: A Comprehensive Review
Rahul Singh, Dalia Biswas
Cureus (2023)
Open Access | Times Cited: 9
Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats
Jessica M. Illenberger, Francisco J. Flores‐Ramirez, Alessandra Matzeu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Opioid-induced neuroanatomical, microglial and behavioral changes are blocked by suvorexant without diminishing opioid analgesia
R. L. McGregor, Ming-Fung Wu, Thomas C. Thannickal, et al.
Nature Mental Health (2024) Vol. 2, Iss. 9, pp. 1018-1031
Closed Access | Times Cited: 3
Orexin-mediated Motivated Arousal and Reward Seeking.
Theresa E. Bjorness, Robert Greene
Peptides (2024) Vol. 180, pp. 171280-171280
Closed Access | Times Cited: 3
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Aida Mohammadkhani, Caitlin Mitchell, Morgan H. James, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
Diversity in the lateral hypothalamic input to the ventral tegmental area
Nathan Godfrey, Stephanie L. Borgland
Neuropharmacology (2019) Vol. 154, pp. 4-12
Closed Access | Times Cited: 29
The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task
Joost Wiskerke, Morgan H. James, Gary Aston‐Jones
Brain Research (2019) Vol. 1731, pp. 146222-146222
Open Access | Times Cited: 26
Activated Wake Systems in Narcolepsy Type 1
Ling Shan, Suzan Linssen, Zoe Harteman, et al.
Annals of Neurology (2023) Vol. 94, Iss. 4, pp. 762-771
Open Access | Times Cited: 8
Introduction to the Special Issue: “Making orexin-based therapies for addiction a reality: What are the steps from here?”
Morgan H. James, Gary Aston‐Jones
Brain Research (2020) Vol. 1731, pp. 146665-146665
Open Access | Times Cited: 22
Targeting the Orexin System for Prescription Opioid Use Disorder
Alessandra Matzeu, Rémi Martin‐Fardon
Brain Sciences (2020) Vol. 10, Iss. 4, pp. 226-226
Open Access | Times Cited: 22
Sensitivity of Hypocretin System to Chronic Alcohol Exposure: A Human and Animal Study
R. L. McGregor, Alessandra Matzeu, Thomas C. Thannickal, et al.
Neuroscience (2023) Vol. 522, pp. 1-10
Open Access | Times Cited: 7

Scroll to top